TLR7 and influenza: A recent study reported that the polymer-nanoparticle (PNP) hydrogel-based subcutaneous delivery of the HA protein along with a TLR7/8 adjuvant in a mouse model could increase the magnitude and duration of the antibody titers after a single injection [126], suggesting an effective vaccine delivery platform that enhances the efficacy of influenza subunit vaccines.